Skip to main content

Vaccine Confidence

The Last Mile: Overcoming COVID-19 Vaccine Hesitancy

There is light at the end of the pandemic tunnel in the US, thanks to the rapid development and efficient distribution of safe and effective COVID-19 vaccines. We have plenty of reasons to rejoice, but a lingering and frustrating impediment to attaining nationwide herd immunity persists—continued vaccine hesitancy fueled by misinformation, especially among particular segments of the US population …

Schaffner Report: COVID-19 Vaccine Safety Update

Following a thorough safety review, FDA and CDC have determined that the recommended pause regarding the use of the Johnson & Johnson COVID-19 vaccine in the US should be lifted and use of the vaccine should resume. In this episode of the Schaffner Report, NFID Medical Director William Schaffner, MD, talks with NFID Executive Director and CEO Marla Dalton about the decision and how it may impact confidence in COVID-19 vaccines …

Black History Month: Vaccine Voices for COVID-19 Vaccine Choices

As we continue to tackle health equity issues, it is important to be open to embracing new partners and creating new champions. Although highlighting the contributions of Black scientists during Black History Month is important, addressing health equity can and should be done anytime and anywhere …

The Urgent Need to Build Vaccine Confidence among US Black Adults

Only 49 percent of US Black adults plan to get a COVID-19 vaccine, and 54 percent have received or plan to get an influenza (flu) vaccine during the 2020-2021 flu season. These findings were among the results of a new survey of US Black adults conducted by NFID to better understand beliefs about COVID-19 and flu, as well as attitudes and practices around vaccination …